Live Breaking News & Updates on Sinovac Research

Stay updated with breaking news from Sinovac research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Xinhua Headlines: A disrupted world to embrace more challenges in post-pandemic era


news
Xinhua Headlines: A disrupted world to embrace more challenges in post-pandemic era
He Fei,Dong Yue,Gao Wencheng,Zhao Manjun,Liu Wanli
Xinhua Headlines: A disrupted world to embrace more challenges in post-pandemic era
Replay Video
UP NEXT
In 2021, new waves of COVID-19 infections from the ravaging pandemic are still one of the most threatening challenges facing the world at large;
With the pandemic still raging and some new COVID-19 variants being more contagious, recent surges in COVID-19 cases have added uncertainty to the eagerly-anticipated global economic recovery;
Instability and social unrest remain as a major theme for some regions this year, which asks for unremitting efforts of relevant parties to cool down tensions and maintain negotiations to find a way out. ....

United Kingdom , New York , United States , Republic Of , Han I , United Arab Emirates , Bruxelles Capitale , City Of , Belarus General , World Health Organization , Al Qahirah , Saudi Arabia , Ding Long , Henadz Zhinkov Xinhua , Xinhua Chen Zhonghao , Xinhua Han Yan , Anthony Fauci , Tedros Adhanom Ghebreyesus , Alicia Barcena , Tofik Babayev Xinhua , Asia Pacific , Xinhua Wang Ying , Xinhua Zhang Yuwei , European Union Handout , Johns Hopkins University , United Nations Economic Commission For Latin America ,

China approves Sinopharm Covid-19 vaccine


China approves Sinopharm Covid-19 vaccine, promises free shots for all citizens
CNN
12/31/2020
By Nectar Gan, CNN
© Zhang Yuwei/Xinhua/Getty Images
BEIJING, April 14, 2020 . A staff member tests samples of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group ,Sinopharm, in Beijing, capital of China, April 11, 2020. China has approved two COVID-19 inactivated vaccine candidates for clinical trials, according to the State Council joint prevention and control mechanism against the coronavirus Tuesday. The two vaccine candidates are developed by Wuhan Institute of Biological Products under the China National Pharmaceutical Group ,Sinopharm, and Sinovac Research and Development Co., Ltd, a company based in Beijing. Clinical trials of the two vaccines have started. (Photo by Zhang Yuwei/Xinhua via Getty) (Xinhua/Zhang Yuwei via Getty Images) ....

United Arab Emirates , United States , United Kingdom , Getty Xinhua Zhang Yuwei , Liu Jingzhen , Zhang Yuwei Xinhua , Zhang Yuwei Xinhua Getty , Zeng Yixin , Development Co Ltd , China National Pharmaceutical Group , World Health Organization , Sinovac Research , China National Health Commission , Products Institute Co , United Kingdom Oxford University , National Medical Products Administration , Wuhan Institute Of Biological Products , State Council , Wuhan Institute , Biological Products , Zhang Yuwei , Getty Images , National Health Commission , National Medical Products , Oxford University , Lunar New Year ,